Timothy Schmidt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Timothy Schmidt has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Calvin Nicklaus Steussy
Purdue University West Lafayette
2 shared publications - Cynthia V. Stauffacher
Purdue University West Lafayette
2 shared publications - Olaf Wiest
University of Notre Dame
2 shared publications - Paul Helquist
University of Notre Dame
2 shared publications - Andrew D. Mesecar
Purdue University, West Lafayette, Indiana 47907, United States
1 shared publication - Anthony R. Rosales
University of Notre Dame
1 shared publication
Latest Publications
- Open Access
- 24 January 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Watching Pseudomonas mevalonii HMG-CoA Reductase in Action
HMG CoA Reductase catalyzed the interconversion of a thioester, HMG CoA, and mevalonic acid, a key step in the isoprenoid pathway, through a complex reaction mechanism involving three distinct chemical steps with two molecules of cofactor and large-scale rearrangements of the enzyme. Here, we investigate the second step, the formation of a thiohemiacetal from CoA and mevaldehyde, using time resolved crystallography and molecular dynamics (MD) simulations. After triggering the reaction by a pH jump from pH 6.7 to pH9, the formation of the carbon-sulfur bond can be observed in the two structures at 2.5 and 4 minutes. The structures obtained close to the activated complex of the reaction serve as the starting point for MD simulations of different possible protonation states of the catalytically active residues. Changes to the active site geometry, specifically the residues Ser 85, Glu 83 and His 381 that are important for catalysis of the reaction are discussed in detail. This work demonstrates the applicability of the combination of time resolved crystallography using a pH trigger with D simulations to obtain a detailed view of a complex reaction in an enzyme active site.
- 24 January 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessWatching Pseudomonas mevalonii HMG-CoA Reductase in Action
HMG CoA Reductase catalyzed the interconversion of a thioester, HMG CoA, and mevalonic acid, a key step in the isoprenoid pathway, through a complex reaction mechanism involving three distinct chemical steps with two molecules of cofactor and large-scale rearrangements of the enzyme. Here, we investigate the second step, the formation of a thiohemiacetal from CoA and mevaldehyde, using time resolved crystallography and molecular dynamics (MD) simulations. After triggering the reaction by a pH jump from pH 6.7 to pH9, the formation of the carbon-sulfur bond can be observed in the two structures at 2.5 and 4 minutes. The structures obtained close to the activated complex of the reaction serve as the starting point for MD simulations of different possible protonation states of the catalytically active residues. Changes to the active site geometry, specifically the residues Ser 85, Glu 83 and His 381 that are important for catalysis of the reaction are discussed in detail. This work demonstrates the applicability of the combination of time resolved crystallography using a pH trigger with D simulations to obtain a detailed view of a complex reaction in an enzyme active site.
- Open Access
pH dependent inhibition from ammonium ions in the Pseudomonas mevalonii HMG-CoA Reductase crystallization environment
HMG-CoA reductase ( Pseudomonas mevalonii ) utilizes mevalonate, coenzyme A (CoA) and the cofactor NAD in a complex mechanism involving two hydride transfers with cofactor exchange, accompanied by large conformational changes by a 50 residue subdomain, to generate HMG-CoA. Details about this mechanism such as the conformational changes that allow intermediate formation, cofactor exchange and product release remain unknown. The formation of the proposed intermediates has also not been observed in structural studies with natural substrates. Having been shown to be an essential enzyme for the survival of gram-positive antibiotic resistant pathogenic bacteria, studying its mechanism in detail will be beneficial in developing novel antibacterials. The enzyme has been shown to be catalytically active inside the crystal with dithio-HMG-CoA and NADH but curiously is found to be inactive in the reverse direction in the structure bound to mevalonate, CoA and NAD. To understand the factors limiting activity in the HMGR crystal with mevalonate, CoA and NAD, we studied the effect of crystallization components and pH on enzymatic activity. We observed a strong inhibition in the crystallization buffer and an increase in activity with increasing pH. We attribute this inhibitive effect to the presence of ammonium ions present in the crystal since inhibition is also observed with several other ammonium salt buffers. Additionally, the lack of inhibition was observed in the absence of ammonium. The effect of each ligand (mevalonate, CoA and NAD) on the rate of the enzymatic reaction in the crystallization environment was further investigated by measuring their K m in the crystallization buffer. The K m measurements indicate that the hydride transfer step between NAD and mevalonate is inhibited in the crystallization environment. To test this further, we solved a crystal structure of pmHMGR bound to the post-hydride transfer intermediate (mevaldehyde) and cofactor Coenzyme A. The resulting turnover with the formation of a thiohemiacetal indicated that the crystallization environment inhibited the oxidative acylation of mevalonate and the reaction intermediate mevaldyl-CoA.
Open AccesspH dependent inhibition from ammonium ions in the Pseudomonas mevalonii HMG-CoA Reductase crystallization environment
HMG-CoA reductase ( Pseudomonas mevalonii ) utilizes mevalonate, coenzyme A (CoA) and the cofactor NAD in a complex mechanism involving two hydride transfers with cofactor exchange, accompanied by large conformational changes by a 50 residue subdomain, to generate HMG-CoA. Details about this mechanism such as the conformational changes that allow intermediate formation, cofactor exchange and product release remain unknown. The formation of the proposed intermediates has also not been observed in structural studies with natural substrates. Having been shown to be an essential enzyme for the survival of gram-positive antibiotic resistant pathogenic bacteria, studying its mechanism in detail will be beneficial in developing novel antibacterials. The enzyme has been shown to be catalytically active inside the crystal with dithio-HMG-CoA and NADH but curiously is found to be inactive in the reverse direction in the structure bound to mevalonate, CoA and NAD. To understand the factors limiting activity in the HMGR crystal with mevalonate, CoA and NAD, we studied the effect of crystallization components and pH on enzymatic activity. We observed a strong inhibition in the crystallization buffer and an increase in activity with increasing pH. We attribute this inhibitive effect to the presence of ammonium ions present in the crystal since inhibition is also observed with several other ammonium salt buffers. Additionally, the lack of inhibition was observed in the absence of ammonium. The effect of each ligand (mevalonate, CoA and NAD) on the rate of the enzymatic reaction in the crystallization environment was further investigated by measuring their K m in the crystallization buffer. The K m measurements indicate that the hydride transfer step between NAD and mevalonate is inhibited in the crystallization environment. To test this further, we solved a crystal structure of pmHMGR bound to the post-hydride transfer intermediate (mevaldehyde) and cofactor Coenzyme A. The resulting turnover with the formation of a thiohemiacetal indicated that the crystallization environment inhibited the oxidative acylation of mevalonate and the reaction intermediate mevaldyl-CoA.